Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study

Дата публикации: 24-10-2026 09:27:13

An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. The findings, published in Nature Medicine, will help researchers design a larger phase 3 clinical trial.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Vaccine may ‘intercept’ pancreatic cancer before it starts	0	13.27	16-07-2026
2	A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning	0	7.74	23-10-2026
3	A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning	0	7.74	23-10-2026
4	A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning	0	7.74	23-10-2026
5	A hidden immune backup system could supercharge mRNA cancer vaccines	0	9.29	09-07-2026
6	Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time	5	8	07-07-2026
7	Interactive: A cancer vaccine is being tailored to individuals	0	12.1	19-08-2026
8	Moderna's cancer vaccine cuts melanoma recurrence risk in early trial: What we know	0	7.73	26-08-2026
9	Найден способ "научить" иммунитет самостоятельно бороться с раком кожи	0	9.44	19-08-2026
10	Overlooked 'off switch' in lung tumors may explain why immunotherapy doesn't work for everyone	0	6.87	23-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.43. Источник: medicalxpress.com.